Qin An¹, Jun Gao², Zhiqin Sang³, Mingyi Qian^4,*

International Journal of Mental Health Promotion, Vol.23, No.1, pp. 87-98, 2021, DOI:10.32604/IJMHP.2021.014422 - 19 February 2021

Abstract When COVID-19 pandemic hit China, Chinese clinical psychologists, counselors and other practitioners reacted quickly to provide psychological interventions for different target groups. Different professional ethical concerns and potential transgressions arose during different stages of pandemic. This paper aimed to summarize different ethical concerns and transgressions during different stages of pandemic in China, as well as how the professional ethical workgroup in the registration system of clinical psychologists and professional organizations of Chinese Psychological Society (CPS) to publish a series of documents as recommendations on ethical practice. It is hoped by providing a picture of “problems vs. More >

Mark Mann¹, Brian P. Calio¹, James Ryan Mark¹, Raju Chelluri², Erich Hufnagel³, Adam Reese⁴, Costas D. Lallas¹, Edouard J. Trabulsi¹, Thenappan Chandrasekar¹, Patrick J. Shenot¹, Ethan Halpern⁵, Leonard G. Gomella¹

Canadian Journal of Urology, Vol.27, No.1, pp. 10099-10104, 2020

Abstract Introduction: To assess whether standard American Urological Association (AUA) and other recommendations for prostate biopsy prophylaxis provide sufficient coverage of common urinary organisms responsible for post biopsy infections by comparing local antibiograms in Philadelphia-area hospitals.
Materials and methods: De-identified culture results derived from antibiograms were collected from six academic and community hospitals in the Philadelphia region. Analysis specifically focused on four major bacterial causes of urinary tract infection following prostate biopsy (Escherichia coli (E. coli), Klebsiella pneumoniae, Proteus mirabilis and Enterococcus faecalis) along with commonly recommended antibiotics including fluoroquinolones (FQ’s), trimethoprim/sulfamethoxazole, ceftriaxone, and gentamicin.
Results: Bacterial sensitivities to… More >

Joaquin Michel¹, Andrew T. Lenis¹, Patrick M. Lec¹, Vishnukam Golla¹, David C. Johnson², Kiran Gollapudi³, Jeremy Blumberg³, Brian M. Shuch^1,4, Karim Chamie^1,4

Canadian Journal of Urology, Vol.27, No.4, pp. 10285-10293, 2020

Abstract Introduction: Renal mass biopsy (RMB) may not be indicated when the results are unlikely to impact management, such as in young and/or healthy patients and in elderly and/or frail patients. We analyzed the utility of RMB in three patient cohorts stratified by age-adjusted Charlson comorbidity index score (ACCI).
Materials and methods: We identified patients with cT1a renal tumors in the National Cancer Database from 2004-2014. We combined age and Charlson-Deyo scores to identify young and/or healthy patients (“healthy-ACCI”), elderly and/or frail patients (“frail-ACCI”), and a reference cohort. We performed multivariable logistic regression to identify predictors of RMB… More >

Lydia Glick¹, Thenappan Chandrasekar¹, Scott G. Hubosky¹, Seth Teplitsky², Mihir Shah³, Joon Yau Leong¹, Geoffrey Ouma⁴, James R. Mark¹

Canadian Journal of Urology, Vol.27, No.6, pp. 10480-10487, 2020

Abstract Appropriate perioperative management of antithrombotic medications is critical; for every patient, the risk of bleeding must be balanced against individual risk of thrombosis. There has been a rapid influx of new antithrombotic therapies in the past 5 years, yet there is a lack of clear and concise guidelines on the management of anticoagulant and antiplatelet therapy during urologic surgery. Here we describe our approach to perioperative antithrombotic counseling, including the timing of stopping and restarting these medications. These practice guidelines have been developed in consultation with the Vascular Medicine service at our institution as well More >

Soham Dasgupta, Glen Iannucci, Chad Mao, Martha Clabby, Matthew E. Oster

Congenital Heart Disease, Vol.14, No.5, pp. 868-877, 2019, DOI:10.1111/chd.12835

Abstract Myocarditis has a variable clinical presentation and there is still debate regarding accurate diagnostic criteria. Adding to the controversy surrounding this diagnosis, there is no clear consensus for the treatment or ongoing follow‐up of patients with myocarditis. All of this makes the diagnosis and management of myocarditis a par‐ ticular challenge in the pediatric population. Furthermore, the literature with respect to this topic is dynamic and ever‐changing. In this review article, we aim to review and summarize the common clinical presentations of myocarditis, along with the latest recommendations for diagnostic criteria, treatment, and follow‐up of More >

Samuel G. Antoine, Alexander C. Small, James M. McKiernan, Ojas Shah

Canadian Journal of Urology, Vol.25, No.1, pp. 9168-9178, 2018

Abstract Introduction: Surgical subspecialty societies release clinical practice guidelines (CPGs) to provide topic-specific recommendations to healthcare providers. We hypothesize that there may be significant differences in statement strength and evidence quality both within the American Urological Association (AUA) guidelines and compared to those published by the American Academy of Orthopedic Surgeons (AAOS) and the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS).
Materials and methods: CPGs issued through 2017 were extracted from AUAnet.org. Statements were characterized by evidence basis, strength, and evidence quality. CPGs were compared among urologic subspecialties and to those from the AAOS and AAO-HNS. Analysis… More >

Heather Y. Sun¹, James A. Proudfoot², Rachel T. McCandless¹

Congenital Heart Disease, Vol.13, No.5, pp. 748-756, 2018, DOI:10.1111/chd.12648

Abstract Background: Fetal echocardiography can accurately diagnose critical congenital heart disease prenatally, but relies on referrals from abnormalities identified on routine obstetrical ultrasounds. Critical congenital heart disease that is frequently missed due to inadequate outflow tract imaging includes anomalies such as truncus arteriosus, double outlet right ventricle, transposition of the great arteries, tetralogy of Fallot, pulmonary stenosis, and aortic stenosis.
Objective: This study evaluated the prenatal detection rate of critical outflow tract anomalies in a single urban pediatric hospital before and after “AIUM Practice Guideline for the Performance of Obstetric Ultrasound Examinations,” which incorporated outflow tract imaging.
Design: Infants… More >

Rohini K. Hernandez¹, Karynsa Cetin¹, Melissa Pirolli², Jane Quigley², David Quach², Paul Smith³, Scott Stryker¹, Alexander Liede¹

Canadian Journal of Urology, Vol.22, No.4, pp. 7858-7864, 2015

Abstract Introduction: Canadian guidelines define castration-resistant prostate cancer (CRPC) at high risk of developing metastases using PSA doubling time (PSADT) <8 months, whereby men may be offered more frequent bone scans/imaging. We evaluated PSA data from nonmetastatic (M0) prostate cancer patients treated at urology and oncology clinics across the United States (US) to describe the proportion and characteristics of patients who met CRPC and high-risk criteria.
Materials and methods: We identified M0 prostate cancer patients aged ≥18 years receiving androgen deprivation therapy (ADT) in 2011 from electronic health records (EHR), covering 129 urology and 64 oncology practices across… More >

Leonard G. Gomella¹, Xiaolong S. Liu¹, Edouard J. Trabulsi¹, Wm. Kevin Kelly², Ronald Myers², Timothy Showalter³, Adam Dicker³, Richard Wender⁴

Canadian Journal of Urology, Vol.18, No.5, pp. 5875-5883, 2011

Abstract Introduction: Prostate cancer presents a global public health dilemma. While screening with prostate specific antigen (PSA) has led to more men diagnosed with prostate cancer than in previous years, the potential for negative effects from over-diagnosis and treatment cannot be ignored.
Materials and methods: We reviewed Medline for recent articles that discuss clinical trials, evidence based recommendations and guidelines from major medical organizations in the United States and worldwide concerning prostate cancer screening.
Results: Results from the European Randomized Screening for Prostate Cancer (ERSPC), the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, and Göteborg Swedish trials… More >

Ravinder Mohan¹, Hind Beydoun², John Davis³, Raymond Lance⁴, Paul Schellhammer⁴

Canadian Journal of Urology, Vol.17, No.1, pp. 4975-4984, 2010

Abstract Introduction: Treatment for localized prostate cancer (LPC) may not improve survival and commonly impairs health related quality of life. National guidelines provide algorithms to choose between treatment or observation for LPC, but the algorithms require the factoring of the patient's baseline comorbidity adjusted life expectancy (CALE). However, no method is available to estimate CALE of 10 or more years.
Materials and methods: A mailed survey was completed by newly diagnosed untreated LPC patients. Their baseline CALE was estimated by weighting their age based life expectancy by quartiles of comorbidity scores, and a national guideline was used to… More >